Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone/Metformin Fixed Combination in Diabetic Dyslipidemia
NCT00770653Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by Takeda. Started Apr 2007; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on NCT00770653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770653.